10-Q: TruBridge Inc. Reports Mixed Q2 Results Amidst Strategic Shift and Reorganization

TruBridge, Inc. reported a net loss for the second quarter of 2024, impacted by strategic changes and increased expenses, despite revenue growth in its RCM segment.

Summary

• TruBridge, Inc. reported a net loss of $5.0 million for the second quarter of 2024, compared to a net loss of $2.8 million in the same period last year.
• Total revenue remained relatively flat at $84.7 million, with a 13% increase in RCM revenue offset by a 17% decrease in EHR revenue.
• The company's RCM segment saw revenue growth due to the acquisition of Viewgol, which contributed $5.2 million in revenue during the quarter.
• EHR revenue declined due to the sale of American HealthTech (AHT) and a shift towards SaaS licensing models.
• Operating expenses increased due to higher amortization and depreciation, severance costs, and non-recurring charges.
• The company's effective tax rate decreased to 29.6% from 36.8% in the same period last year, primarily due to a decrease in the impact of state deferred taxes and the research and development tax credit.
• For the first six months of 2024, the company reported a net loss of $7.6 million, compared to a net income of $0.2 million in the same period last year.
• The company's twelve-month backlog is approximately $10 million for non-recurring system purchases and $318 million for recurring payments under support, maintenance, and RCM services.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive aspects like RCM growth, but the overall sentiment is negative due to the net loss, declining EHR revenue, and material weakness in internal controls. The strategic shift and reorganization also add uncertainty.

Positives

• RCM revenue increased by 13% in Q2 2024, driven by the acquisition of Viewgol and new contracts.
• The company's effective tax rate decreased to 29.6% in Q2 2024, compared to 36.8% in Q2 2023.
• The company's twelve-month backlog is approximately $328 million.
• The company has seen a substantially diminished need for the issuance of customer credits.

Negatives

• The company experienced a net loss of $5.0 million in Q2 2024, compared to a net loss of $2.8 million in Q2 2023.
• EHR revenue decreased by 17% in Q2 2024, primarily due to the sale of AHT and a shift towards SaaS licensing.
• Operating expenses increased due to higher amortization and depreciation, severance costs, and non-recurring charges.
• The company has a material weakness in internal control over financial reporting related to customer contract changes and terminations.

Risks

• The company faces risks related to market saturation, economic conditions, and regulatory uncertainty in the healthcare industry.
• The transition to a subscription-based recurring revenue model and modernization of technology pose challenges.
• The company faces competition from companies with greater financial and technical resources.
• Potential future acquisitions may be expensive and time-consuming.
• The company's operations could be disrupted due to the implementation of a new enterprise resource planning software solution.
• The company is exposed to numerous and often conflicting laws, regulations, policies, standards or other requirements through its international business activities.
• The company is exposed to competitive and litigation risk related to the use of artificial intelligence.
• The company has a material weakness in internal control over financial reporting.
• The company's Rights Agreement includes terms and conditions that could discourage a takeover or other transactions that stockholders may consider favorable.

Future Outlook

The company expects the trend of customers preferring SaaS arrangements to continue, which will impact short-term revenue and profitability but benefit long-term growth. The company also aims to grow through cross-selling RCM services, expanding RCM market share, and pursuing competitive EHR opportunities.

Management Comments

• Management believes adjusted EBITDA is a useful measure to assess the performance and liquidity of the Company.
• Management believes that the company's funding sources, taken together with the future operating cash flows of the combined entity, provide adequate resources to fund ongoing cash requirements for the next twelve months and beyond.
• Management is working to strengthen the company's internal controls and improve its procedures for processing customer contract changes and terminations and issuing credits to customers.

Industry Context

The healthcare industry is experiencing increasing pressure to reduce costs and increase quality, which is driving adoption of healthcare IT and demand for business management and consulting services. The shift towards value-based reimbursement models is also influencing the industry. The company is adapting to these trends by focusing on RCM services and SaaS offerings.

Comparison to Industry Standards

• The company's shift towards SaaS licensing is consistent with industry trends, where many healthcare providers are moving away from large upfront capital expenditures for software.
• The company's focus on recurring revenue streams aligns with the industry's move towards subscription-based models, which provide more predictable revenue.
• The company's RCM growth is in line with the increasing demand for outsourced revenue cycle management services in the healthcare sector.
• The company's challenges in EHR revenue are reflective of the competitive landscape and the need to adapt to changing customer preferences.
• The company's financial performance is being impacted by the transition to SaaS, similar to other companies in the industry undergoing this shift.

Stakeholder Impact

• Shareholders are negatively impacted by the net loss and declining stock price.
• Employees may be affected by ongoing restructuring and cost-cutting measures.
• Customers may experience changes in service delivery due to the company's strategic shift.
• Creditors are impacted by the company's debt levels and covenant compliance.

Next Steps

• The company will continue to focus on cross-selling RCM services into its existing EHR customer base.
• The company will continue to expand RCM market share with sales to new community hospitals and larger health systems.
• The company will continue to pursue competitive EHR takeaway opportunities in the acute care markets.
• The company will continue to work to improve its internal control over financial reporting.
• The company will continue to evaluate the use of technology and automation to enhance further preventative controls and ensure a complete and up-to date inventory of customer contract modifications.

Key Dates

Keywords

Revenue Cycle Management, Electronic Health Records, Healthcare IT, SaaS, Financial Results, Acquisition, Software Development, Amortization, Operating Expenses, Net Loss